Home › Funds › Gladius Capital Management LP › JNJ

Gladius Capital Management LP position in JNJ

JOHNSON & JOHNSON · Health Care

Gladius Capital Management LP reported holding 82,300 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$21.8M, representing 1.55% of its reported portfolio and ranking #18 among its reported holdings. Gladius Capital Management LP has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)82.30K sh
Reported value held$21.79M
Portfolio Weight1.55%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Gladius Capital Management LP's JNJ position evolved

Gladius Capital Management LP first disclosed a stake in JNJ in Q3 2023 at 32,374 shares (US$5.0M). The position peaked in Q2 2026 at 157,400 shares, worth US$40.0M. Across 13 filings, Gladius Capital Management LP increased the stake 4 time(s), trimmed it 8 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 82,300 shares valued at US$21.8M — a reduction of -75,100 shares quarter over quarter.. Notable position changes include a 223% increase in Q2 2024 (shares rose 11% over the following quarter), a 1477% increase in Q3 2025 (shares rose 11% over the following quarter), a 4419% increase in Q1 2026 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 32.37K $5.04M New
Q4 2023 5.40K $846.71K Reduce
Q1 2024 4.72K $746.66K Reduce
Q2 2024 15.26K $2.23M Add
Q3 2024 12.74K $2.07M Reduce
Q4 2024 12.40K $1.79M Reduce
Q1 2025 6.03K $999.52K Reduce
Q2 2025 1.30K $198.57K Reduce
Q3 2025 20.50K $3.80M Add
Q4 2025 1.66K $343.95K Reduce
Q1 2026 75.10K $18.36M Add
Q2 2026 157.40K $39.97M Add
Q3 2026 82.30K $21.79M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Gladius Capital Management LP held JNJ?

Gladius Capital Management LP has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Gladius Capital Management LP's current position in JNJ?

As of Q3 2026, Gladius Capital Management LP holds 82.30K shares of JNJ (JOHNSON & JOHNSON), valued at $21.79M, representing 1.55% of its reported portfolio and ranking #18.

Has Gladius Capital Management LP been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Gladius Capital Management LP reduced its position in JNJ. The position peaked in Q2 2026 at 157.40K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.